Edna Mora

2.2k total citations
24 papers, 789 citations indexed

About

Edna Mora is a scholar working on Molecular Biology, Nutrition and Dietetics and Oncology. According to data from OpenAlex, Edna Mora has authored 24 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Nutrition and Dietetics and 5 papers in Oncology. Recurrent topics in Edna Mora's work include Vitamin C and Antioxidants Research (6 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Edna Mora is often cited by papers focused on Vitamin C and Antioxidants Research (6 papers), Breast Cancer Treatment Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). Edna Mora collaborates with scholars based in United States, Puerto Rico and United Kingdom. Edna Mora's co-authors include Hugh D. Riordan, Michael J. González, Neil H Riordan, Jorge R. Miranda-Massari, Gabriel Lopez‐Berestein, Anil K. Sood, Sun Joo Lee, Hee Dong Han, Rebecca L. Stone and Ju‐Won Roh and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Edna Mora

24 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edna Mora United States 14 364 185 129 128 104 24 789
Jingying Xiang China 15 378 1.0× 209 1.1× 73 0.6× 149 1.2× 88 0.8× 21 796
Dilek Telci Türkiye 19 383 1.1× 48 0.3× 124 1.0× 112 0.9× 75 0.7× 58 1.2k
Qianqian Yu China 21 552 1.5× 144 0.8× 133 1.0× 98 0.8× 184 1.8× 37 1.0k
Suraj K. George United States 14 204 0.6× 44 0.2× 90 0.7× 63 0.5× 83 0.8× 23 518
Bing Ji China 16 450 1.2× 47 0.3× 93 0.7× 251 2.0× 95 0.9× 29 802
Ai Huang China 17 365 1.0× 60 0.3× 141 1.1× 131 1.0× 195 1.9× 59 1.1k
Binhua Zou China 13 395 1.1× 96 0.5× 215 1.7× 67 0.5× 294 2.8× 23 927
Hazel C. Cable United Kingdom 13 396 1.1× 49 0.3× 204 1.6× 60 0.5× 55 0.5× 20 847
Sameera Nallanthighal United States 9 290 0.8× 65 0.4× 56 0.4× 163 1.3× 93 0.9× 13 705

Countries citing papers authored by Edna Mora

Since Specialization
Citations

This map shows the geographic impact of Edna Mora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edna Mora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edna Mora more than expected).

Fields of papers citing papers by Edna Mora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edna Mora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edna Mora. The network helps show where Edna Mora may publish in the future.

Co-authorship network of co-authors of Edna Mora

This figure shows the co-authorship network connecting the top 25 collaborators of Edna Mora. A scholar is included among the top collaborators of Edna Mora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edna Mora. Edna Mora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ortíz, Ana P., L. Henry Garland, Kristine Jones, et al.. (2018). A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico. Cancers. 10(11). 419–419. 17 indexed citations
2.
Mora, Edna, et al.. (2015). Proceedings of the 1<sup>st</sup> Puerto Rico Biobanking Workshop. Reviews on Recent Clinical Trials. 9(4). 233–244. 1 indexed citations
3.
Castro, Cristina, et al.. (2013). Synthesis, stability, cellular uptake, and blood circulation time of carboxymethyl-inulin coated magnetic nanoparticles. Journal of Materials Chemistry B. 1(22). 2807–2807. 35 indexed citations
4.
Ortíz, Ana P., et al.. (2013). Breast cancer molecular subtypes and survival in a hospital‐based sample in Puerto Rico. Cancer Medicine. 2(3). 343–350. 18 indexed citations
5.
Shahzad, Mian M.K., Koji Matsuo, Chunhua Lu, et al.. (2012). Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma. Cancer Letters. 330(2). 123–129. 23 indexed citations
6.
Han, Hee Dong, Edna Mora, Ju‐Won Roh, et al.. (2011). Chitosan hydrogel for localized gene silencing. Cancer Biology & Therapy. 11(9). 839–845. 65 indexed citations
7.
Han, Hee Dong, Lingegowda S. Mangala, Jeong Won Lee, et al.. (2010). Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles. Clinical Cancer Research. 16(15). 3910–3922. 202 indexed citations
8.
Ortíz, Ana P., et al.. (2010). Clinicopathological factors associated to HER-2 status in a hospital-based sample of breast cancer patients in Puerto Rico.. PubMed. 29(3). 265–71. 3 indexed citations
9.
Stone, Rebecca L., Alpa M. Nick, Vahid Afshar‐Kharghan, et al.. (2010). Abstract 3436: Mechanisms of paraneoplastic thrombocytosis in ovarian carcinoma. Cancer Research. 70(8_Supplement). 3436–3436. 1 indexed citations
10.
Simeone, Ann‐Marie, Stefano Colella, Ralf Krahe, et al.. (2005). N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Carcinogenesis. 27(3). 568–577. 32 indexed citations
11.
González, Michael J., Jorge R. Miranda-Massari, Edna Mora, et al.. (2005). Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later. Integrative Cancer Therapies. 4(1). 32–44. 105 indexed citations
12.
Riordan, Neil H, Hugh D. Riordan, Nina Mikirova, et al.. (2004). Cell membrane fatty acid composition differs between normal and malignant cell lines.. PubMed. 23(2). 103–6. 29 indexed citations
13.
Riordan, Hugh D., Neil H Riordan, James Jackson, et al.. (2004). Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.. PubMed. 23(2). 115–8. 42 indexed citations
14.
González, Michael J., Jorge R. Miranda-Massari, Edna Mora, et al.. (2002). Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.. PubMed. 21(1). 39–41. 7 indexed citations
15.
González, Michael J., Jorge R. Miranda-Massari, Edna Mora, et al.. (2000). Integrative medicine: a paradigm shift in medical education and practice.. PubMed. 19(4). 389–92. 2 indexed citations
16.
González, Michael J., Edna Mora, Neil H Riordan, Hugh D. Riordan, & Pablo Mójica. (1998). Rethinking Vitamin C and Cancer: An Update on Nutritional Oncology. 3(3). 215–224. 10 indexed citations
17.
Mora, Edna, S. Eva Singletary, Aman U. Buzdar, & Dennis A. Johnston. (1996). Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients. Annals of Surgical Oncology. 3(2). 162–168. 12 indexed citations
18.
Sawada, H, Hironao Wakabayashi, Akihiro Nawa, et al.. (1996). Differential motility stimulation but not growth stimulation or adhesion of metastatic human colorectal carcinoma cells by target organ-derived liver sinusoidal endothelial cells. Clinical & Experimental Metastasis. 14(3). 308–313. 12 indexed citations
19.
Kaplan, Sandra S., R. E. Basford, Edna Mora, Myung Ho Jeong, & Richard L. Simmons. (1992). Biomaterial‐induced alterations of neutrophil superoxide production. Journal of Biomedical Materials Research. 26(8). 1039–1051. 48 indexed citations
20.
Mora, Edna, Sandra S. Kaplan, & Richard L. Simmons. (1991). Superoxide release by neutrophils exposed to different biomaterials.. PubMed. 47(6). 430–1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026